GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
7E21 | P54710 | Cryo EM structure of a Na+-bound Na+,K+-ATPase in the E1 state with ATP-gamma-S | |
7X20 | P54708 | Crystal structure of non gastric H,K-ATPase alpha2 in (K+)E2-AlF state | |
7X21 | P54708 | Cryo-EM structure of non gastric H,K-ATPase alpha2 K794A in (K+)E2-AlF state | |
7X22 | P54708 | Cryo-EM structure of non gastric H,K-ATPase alpha2 K794S in (2K+)E2-AlF state | |
7X23 | P54708 | Cryo-EM structure of non gastric H,K-ATPase alpha2 SPWC mutant in 3Na+E1-AMPPCPF state | |
7X24 | P54708 | Cryo-EM structure of non gastric H,K-ATPase alpha2 SPWC mutant in (2K+)E2-AlF state | |
6B2E | P54646 | Structure of full length human AMPK (a2b2g1) in complex with a small molecule activator SC4. | |
7JHG | P54619 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Dorsomorphin (Compound C) and Fab-nanobody | |
7JIJ | P54619 | ATP-bound AMP-activated protein kinase | |
7JHH | P54619 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody | |
6B2E | P54619 | Structure of full length human AMPK (a2b2g1) in complex with a small molecule activator SC4. | |
7M74 | P54619 | ATP-bound AMP-activated protein kinase | |
4RER | P54619 | Crystal structure of the phosphorylated human alpha1 beta2 gamma1 holo-AMPK complex bound to AMP and cyclodextrin | |
1ECE | P54583 | ACIDOTHERMUS CELLULOLYTICUS ENDOCELLULASE E1 CATALYTIC DOMAIN IN COMPLEX WITH A CELLOTETRAOSE | |
1BU8 | P54318 | RAT PANCREATIC LIPASE RELATED PROTEIN 2 | |
2OXE | P54317 | Structure of the Human Pancreatic Lipase-related Protein 2 | |
6CMO | P54311 | Rhodopsin-Gi complex | |
9JR3 | P54311 | Cryo-EM structure of PTH-PTH1R-Gq (tilted state) | |
7FIG | P54311 | luteinizing hormone/choriogonadotropin receptor(S277I)-chorionic gonadotropin-Gs complex | |
7MIY | P54289 | Human N-type voltage-gated calcium channel Cav2.2 at 3.1 Angstrom resolution | |
7VFS | P54289 | Human N-type voltage gated calcium channel CaV2.2-alpha2/delta1-beta1 complex, apo state | |
7VFU | P54289 | Human N-type voltage gated calcium channel CaV2.2-alpha2/delta1-beta1 complex, bound to ziconotide | |
7VFV | P54289 | Human N-type voltage gated calcium channel CaV2.2-alpha2/delta1-beta1 complex, bound to PD173212 | |
7VFW | P54289 | Human N-type voltage gated calcium channel CaV2.2-alpha2/delta1-beta1 complex, bound to CaV2.2-blocker1 | |
8IF3 | P54289 | Structure of human alpha-2/delta-1 with mirogabalin | |
8IF4 | P54289 | Structure of human alpha-2/delta-1 without mirogabalin | |
7YG5 | P54289 | Structure of human R-type voltage-gated CaV2.3-alpha2/delta1-beta1 channel complex in the topiramate-bound state | |
7MIX | P54289 | Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom resolution | |
8EPL | P54289 | Human R-type voltage-gated calcium channel Cav2.3 at 3.1 Angstrom resolution | |
8EPM | P54289 | Human R-type voltage-gated calcium channel Cav2.3 CH2II-deleted mutant at 3.1 Angstrom resolution | |
7UHF | P54289 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of cinnarizine at 3.1 Angstrom resolution | |
7UHG | P54289 | Human L-type voltage-gated calcium channel Cav1.3 at 3.0 Angstrom resolution | |
7XLQ | P54289 | Structure of human R-type voltage-gated CaV2.3-alpha2/delta1-beta1 channel complex in the ligand-free (apo) state | |
8FHS | P54289 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of amiodarone and sofosbuvir at 3.3 Angstrom resolution | |
8E59 | P54289 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution | |
8E5A | P54289 | Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution | |
8E5B | P54289 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone and Sofosbuvir at 3.3 Angstrom resolution | |
8X90 | P54289 | P/Q type calcium channel | |
8X91 | P54289 | P/Q type calcium channel in complex with omega-conotoxin MVIIC | |
8X93 | P54289 | P/Q type calcium channel in complex with omega-Agatoxin IVA | |
8HLP | P54289 | Cryo-EM structure of human high-voltage activated L-type calcium channel CaV1.2 (apo) | |
8HMA | P54289 | Cryo-EM structure of human high-voltage activated L-type calcium channel CaV1.2 in complex with tetrandrine (TET) | |
8HMB | P54289 | Cryo-EM structure of human high-voltage activated L-type calcium channel CaV1.2 in complex with benidipine (BEN) | |
8WE6 | P54289 | Human L-type voltage-gated calcium channel Cav1.2 at 2.9 Angstrom resolution | |
8WE7 | P54289 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution | |
8WE9 | P54289 | Human L-type voltage-gated calcium channel Cav1.2 (Class I) in the presence of pinaverium at 3.0 Angstrom resolution | |
8WEA | P54289 | Human L-type voltage-gated calcium channel Cav1.2 (Class II) in the presence of pinaverium at 3.2 Angstrom resolution | |
8WE8 | P54289 | Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine, amlodipine and pinaverium at 2.9 Angstrom resolution | |
8FD7 | P54286 | Structure of the human L-type voltage-gated calcium channel Cav1.2 complexed with gabapentin | |
8EOG | P54286 | Structure of the human L-type voltage-gated calcium channel Cav1.2 complexed with L-leucine |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024